Detalhe da pesquisa
1.
Human Antibodies for Viral Infections.
Annu Rev Immunol;
40: 349-386, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-35113730
2.
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein.
Cell;
184(9): 2316-2331.e15, 2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33773105
3.
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell;
184(7): 1804-1820.e16, 2021 04 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33691139
4.
Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Cell;
184(22): 5593-5607.e18, 2021 10 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34715022
5.
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.
Cell;
184(17): 4414-4429.e19, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34416146
6.
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell;
184(17): 4430-4446.e22, 2021 08 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34416147
7.
Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
Cell;
183(6): 1536-1550.e17, 2020 12 10.
Artigo
Inglês
| MEDLINE | ID: mdl-33306954
8.
Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection.
Cell;
183(7): 1884-1900.e23, 2020 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-33301709
9.
Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19.
Nat Immunol;
21(12): 1506-1516, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33028979
10.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity;
54(10): 2399-2416.e6, 2021 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34481543
11.
Bispecific antiviral neutralizing antibodies are twice as nice.
Nat Immunol;
23(3): 346-347, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35228693
12.
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization.
Immunity;
52(2): 388-403.e12, 2020 02 18.
Artigo
Inglês
| MEDLINE | ID: mdl-32023489
13.
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains.
Nature;
596(7870): 103-108, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34153975
14.
Potently neutralizing and protective human antibodies against SARS-CoV-2.
Nature;
584(7821): 443-449, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32668443
15.
B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection.
PLoS Pathog;
18(1): e1010179, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34990486
16.
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.
PLoS Pathog;
18(5): e1010518, 2022 05.
Artigo
Inglês
| MEDLINE | ID: mdl-35584193
17.
A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer Interface.
Cell;
177(5): 1136-1152.e18, 2019 05 16.
Artigo
Inglês
| MEDLINE | ID: mdl-31100268
18.
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
Proc Natl Acad Sci U S A;
118(14)2021 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-33782133
19.
Antibody affinity versus dengue morphology influences neutralization.
PLoS Pathog;
17(2): e1009331, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33621239
20.
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection.
Cell;
174(4): 938-952.e13, 2018 08 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30096313